Behavioral changes after acetylcholinesterase inhibition with physostigmine in mice.
about
Cholinergic neuronal defect without cell loss in Huntington's disease.Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor.Extracts and constituents of Leontopodium alpinum enhance cholinergic transmission: brain ACh increasing and memory improving properties.
P2860
Behavioral changes after acetylcholinesterase inhibition with physostigmine in mice.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Behavioral changes after acetylcholinesterase inhibition with physostigmine in mice.
@en
Behavioral changes after acetylcholinesterase inhibition with physostigmine in mice.
@nl
type
label
Behavioral changes after acetylcholinesterase inhibition with physostigmine in mice.
@en
Behavioral changes after acetylcholinesterase inhibition with physostigmine in mice.
@nl
prefLabel
Behavioral changes after acetylcholinesterase inhibition with physostigmine in mice.
@en
Behavioral changes after acetylcholinesterase inhibition with physostigmine in mice.
@nl
P2093
P1476
Behavioral changes after acetylcholinesterase inhibition with physostigmine in mice.
@en
P2093
James B Lucot
Mojmir Mach
Robert D Grubbs
Sara J Paton
William A Price
P304
P356
10.1016/J.PBB.2004.09.009
P407
P577
2004-11-01T00:00:00Z